Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer

BACKGROUND: Whether hazard ratio (HR) of progression-free survival (HRpfs), odds ratio (OR) of response rate (ORrr), OR of disease control rate (ORdcr), and OR of 1-year overall survival (ORos1y) used for extensive-disease small-cell lung cancer (ED-SCLC) correlate with HR of overall survival (HRos)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hao, Horita, Nobuyuki, Ito, Kentaro, Hara, Yu, Kobayashi, Nobuaki, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481618/
https://www.ncbi.nlm.nih.gov/pubmed/32953508
http://dx.doi.org/10.21037/tlcr-20-377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481618/
https://www.ncbi.nlm.nih.gov/pubmed/32953508
http://dx.doi.org/10.21037/tlcr-20-377

Ejemplares similares